Related Experiment Video
Updated: Aug 6, 2026
02:52
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
Published on: March 7, 2025
Zebrafish assays for drug toxicity screening
1Zygogen LLC, 520 Kell Hall, 24 Peachtree Center Avenue, Atlanta, GA 30303, USA. amy@zygogen.com
Expert Opinion on Drug Metabolism & Toxicology
|July 27, 2006
Summary
Zebrafish embryos offer a rapid and cost-effective model for preclinical drug discovery and toxicity testing. Their unique biological characteristics enable efficient compound screening and toxicological assessments.
Area of Science:
- Pharmacology
- Toxicology
- Developmental Biology
Background:
- Zebrafish are increasingly utilized in preclinical drug discovery.
- Zebrafish embryos develop mammalian organ systems within a week.
- Their small size, transparency, and absorption properties facilitate compound screening.
Purpose of the Study:
- To review assays for assessing in vivo toxicity using zebrafish.
- To highlight the utility of zebrafish in pharmacological toxicology.
- To provide examples of conserved toxicity between zebrafish and humans.
Main Methods:
- Utilizing zebrafish embryos for compound absorption and toxicity assessment.
- Employing antisense technology for routine gene function analysis.
- Developing specific assays for pharmacological toxicology in zebrafish.
Main Results:
- Zebrafish embryos exhibit conserved toxicological responses to known human toxicants.
- Gene knockdown and compound screening are feasible in zebrafish.
- Assays are being optimized for in vivo toxicity evaluation.
Conclusions:
- Zebrafish serve as a valuable vertebrate model for preclinical drug discovery.
- Their unique traits facilitate efficient and reliable toxicity screening.
- Further development of zebrafish-based assays will advance pharmacological toxicology research.
